1-3 of 3
Luis M Vence
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Durable Responses with Ipilimumab Plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies

Issa F. Khouri, Jorge A Borin Scutti, Denái R. Milton, Courtney Nicholas, Mariana Pineda, Elias J. Jabbour, MD, Roland L. Bassett, Jr., Shalini S Yadav, Luis M Vence, James P Allison, PhD, Alison Gulbis, Padmanee Sharma, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4585.
https://doi.org/10.1182/blood-2018-99-117814
Published: 2018
Journal Articles

Lenalidomide with Ipilimumab for Lymphoid Malignancies after Allogeneic or Autologous Stem Cell Transplantation (SCT)

Issa F. Khouri, MD, Irina Fernandez Curbelo, PhD, Francesco Turturro, MD, Denái R. Milton, Rang A Kim, Elias J. Jabbour, MD, Roland L Bassett, Jr., Luis M Vence, PhD, Padmanee Sharma, MD PhD, Alison M Gulbis, PharmD
Journal: Blood
Blood (2016) 128 (22): 1164.
https://doi.org/10.1182/blood.V128.22.1164.1164
Published: 2016
Journal Articles

Leukemia-Associated Primary Granule Proteins (PGPs) Elastase-2 and Proteinase-3 Are Aberrantly Expressed in Solid Tumors: A Potential Therapeutic Target for PR1-Directed Immunotherapy

Gheath Alatrash, Luis M Vence, Wendy Woodward, Naoto T Ueno, Jeffrey J Molldrem
Journal: Blood
Blood (2008) 112 (11): 5440.
https://doi.org/10.1182/blood.V112.11.5440.5440
Published: 2008